---
figid: PMC6792082__djy230f7
figlink: /pmc/articles/PMC6792082/figure/djy230-F7/
number: F7
caption: Targeting NRF2 antioxidant pathway for IDH1-mutated cancers. IDHWT cells
  exhibit normal reactive oxygen species (ROS) burden. NRF2 is recognized by KEAP1
  and constitutively removed through proteasomal degradation. In IDH1R132H cells,
  elevated ROS burden leads to NRF2 stabilization, nuclear translocation, and transcriptional
  activation of antioxidant genes. NRF2 downstream genes not only assist ROS homeostasis
  in IDH1-mutated cancer but also serve as potential resistance mechanism for chemotherapies.
pmcid: PMC6792082
papertitle: Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
reftext: Yang Liu, et al. J Natl Cancer Inst. 2019 Oct;111(10):1033-1041.
pmc_ranked_result_index: '104331'
pathway_score: 0.9193101
filename: djy230f7.jpg
figtitle: Targeting NRF2 antioxidant pathway for IDH1-mutated cancers
year: '2019'
organisms: Homo sapiens
ndex: 78d1a59e-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6792082__djy230f7.html
  '@type': Dataset
  description: Targeting NRF2 antioxidant pathway for IDH1-mutated cancers. IDHWT
    cells exhibit normal reactive oxygen species (ROS) burden. NRF2 is recognized
    by KEAP1 and constitutively removed through proteasomal degradation. In IDH1R132H
    cells, elevated ROS burden leads to NRF2 stabilization, nuclear translocation,
    and transcriptional activation of antioxidant genes. NRF2 downstream genes not
    only assist ROS homeostasis in IDH1-mutated cancer but also serve as potential
    resistance mechanism for chemotherapies.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAF
  - WLS
  - ME1
  - KEAP1
  - CUL1
  - G6PD
  - GCLC
  - EP300
  - GCLM
  - HPGDS
  - SON
  - TXNRD1
  - PRDX1
  - GSH
  - NADP
  - Drug excretion
genes:
- word: Maf
  symbol: MAF
  source: hgnc_symbol
  hgnc_symbol: MAF
  entrez: '4094'
- word: (MRP)
  symbol: MRP
  source: hgnc_alias_symbol
  hgnc_symbol: WLS
  entrez: '79971'
- word: NADPsynthesis(G6PD,ME1)
  symbol: ME1
  source: hgnc_symbol
  hgnc_symbol: ME1
  entrez: '4199'
- word: Keap1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: Cul1
  symbol: CUL1
  source: hgnc_symbol
  hgnc_symbol: CUL1
  entrez: '8454'
- word: (G6PD,
  symbol: G6PD
  source: hgnc_symbol
  hgnc_symbol: G6PD
  entrez: '2539'
- word: (GCLC,
  symbol: GCLC
  source: hgnc_symbol
  hgnc_symbol: GCLC
  entrez: '2729'
- word: P300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: GCLM)
  symbol: GCLM
  source: hgnc_symbol
  hgnc_symbol: GCLM
  entrez: '2730'
- word: (GSTS,
  symbol: GSTS
  source: hgnc_alias_symbol
  hgnc_symbol: HPGDS
  entrez: '27306'
- word: SON
  symbol: SON
  source: hgnc_symbol
  hgnc_symbol: SON
  entrez: '6651'
- word: (TXNRD1,
  symbol: TXNRD1
  source: hgnc_symbol
  hgnc_symbol: TXNRD1
  entrez: '7296'
- word: PRDX1)
  symbol: PRDX1
  source: hgnc_symbol
  hgnc_symbol: PRDX1
  entrez: '5052'
chemicals:
- word: GSH
  source: MESH
  identifier: D005978
- word: NADP
  source: MESH
  identifier: D009249
diseases:
- word: Drug excretion
  source: MESH
  identifier: D019966
figid_alias: PMC6792082__F7
redirect_from: /figures/PMC6792082__F7
figtype: Figure
---
